Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13926
PUT
Oportun Financial
OPRT
$393M
| $3.88K | ﹤0.01% |
1,000
-22,600
| -96% | -$72.9K |
2023 Q3
5 quarters
|
|
13927
CALL
GraniteShares 2x Short TSLA Daily ETF
TSDD
$22.5M
| $3.86K | ﹤0.01% |
+115
| New | +$9.93K |
2024 Q4
0 quarters
|
|
13928
CALL
Spruce Power Holding Corp
SPRU
$29.6M
| $3.86K | ﹤0.01% |
+1,300
| New | +$3.41K |
2024 Q4
0 quarters
|
|
13929
CALL
Alerus Financial
ALRS
$806M
| $3.85K | ﹤0.01% |
200
-200
| -50% | -$4.39K |
2024 Q3
1 quarter
|
|
|
FSP
13930
CALL
Franklin Street Properties
FSP
$32.4M
| $3.84K | ﹤0.01% |
2,100
-32,300
| -94% | -$59K |
2022 Q4
8 quarters
|
|
13931
PUT
Kartoon Studios
TOON
$35.8M
| $3.83K | ﹤0.01% |
6,500
+2,000
| +44% | +$1.42K |
2024 Q2
2 quarters
|
|
13932
CALL
CytomX Therapeutics
CTMX
$553M
| $3.81K | ﹤0.01% |
3,700
+700
| +23% | +$753 |
2021 Q4
12 quarters
|
|
|
ORIO
13933
PUT
Orion Digital Corp
ORIO
$24.8M
| $3.81K | ﹤0.01% |
2,800
+2,500
| +833% | +$3.15K |
2024 Q3
1 quarter
|
|
13934
PUT
Five Point Holdings
FPH
$325M
| $3.78K | ﹤0.01% |
1,000
-1,000
| -50% | -$3.92K |
2022 Q4
8 quarters
|
|
|
SLRN
13935
PUT
DELISTED
ACELYRIN
SLRN
| $3.77K | ﹤0.01% |
1,200
-16,400
| -93% | -$79.4K |
2023 Q2
6 quarters
|
|
|
PARAW
13936
Banzai International Warrant
PARAW
$118K
| $3.76K | ﹤0.01% |
315,657
-51,464
| -14% | -$453 |
2023 Q3
5 quarters
|
|
13937
CALL
ProShares Short Russell2000
RWM
$152M
| $3.75K | ﹤0.01% |
200
-10,100
| -98% | -$186K |
2024 Q3
1 quarter
|
|
13938
PUT
Citizens & Northern Corp
CZNC
$456M
| $3.72K | ﹤0.01% |
200
| – | – |
2024 Q3
1 quarter
|
|
13939
PUT
First Bancorp
FBP
$4.14B
| $3.72K | ﹤0.01% |
200
+100
| +100% | +$2.02K |
2024 Q2
2 quarters
|
|
13940
PUT
Pacer Lunt Large Cap Alternator ETF
ALTL
$84.4M
| $3.72K | ﹤0.01% |
+100
| New | +$3.84K |
2024 Q4
0 quarters
|
|
13941
CALL
iShares MSCI Intl Quality Factor ETF
IQLT
$13.7B
| $3.71K | ﹤0.01% |
+100
| New | +$3.91K |
2024 Q4
0 quarters
|
|
|
HYAC.WS
13942
DELISTED
Haymaker Acquisition Corp 4 Warrants
HYAC.WS
| $3.7K | ﹤0.01% |
26,408
-9,989
| -27% | -$1.54K |
2024 Q2
2 quarters
|
|
|
NXPLW
13943
DELISTED
NextPlat Corp Warrants
NXPLW
| $3.7K | ﹤0.01% |
42,985
-9,125
| -18% | -$1.7K |
2023 Q2
6 quarters
|
|
13944
PUT
AGF US Market Neutral Anti-Beta Fund
BTAL
$311M
| $3.7K | ﹤0.01% |
200
+100
| +100% | +$1.92K |
2024 Q3
1 quarter
|
|
13945
CALL
Hope Bancorp
HOPE
$1.75B
| $3.69K | ﹤0.01% |
300
-3,400
| -92% | -$44.2K |
2022 Q4
8 quarters
|
|
13946
CALL
Capital City Bank Group
CCBG
$846M
| $3.67K | ﹤0.01% |
100
| – | – |
2023 Q2
6 quarters
|
|
13947
CALL
IGC Pharma
IGC
$28.8M
| $3.63K | ﹤0.01% |
10,800
-7,900
| -42% | -$2.96K |
2024 Q2
2 quarters
|
|
|
LNAI
13948
CALL
Lunai Bioworks
LNAI
$5.3M
| $3.59K | ﹤0.01% |
54
-55
| -50% | -$3.65K |
2024 Q3
1 quarter
|
|
13949
PUT
Verrica Pharmaceuticals
VRCA
$74M
| $3.57K | ﹤0.01% |
510
-140
| -22% | -$1.54K |
2024 Q2
2 quarters
|
|
13950
CALL
Immunic
IMUX
$109M
| $3.5K | ﹤0.01% |
350
+340
| +3,400% | +$4.28K |
2020 Q3
17 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.